Kyntra Bio KYNB
NASDAQ KYNB
$3.29 -0.20 (-5.73%)
As of: Nov 16, 2026 · 11:42 AM EST

Kyntra Bio (KYNB) EV to EBITDA (2019)

Updated

Kyntra Bio's (KYNB) EV to EBITDA came in at 64.04 for Q3 2019, down 2.5% from the prior quarter.

Analysis

Kyntra Bio (KYNB) EV to EBITDA (2019) Analysis & Trends

For the trailing twelve months through Sep 30, 2019, EV to EBITDA at Kyntra Bio was 18.81.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,292.38 Bn 1,265.99 Bn 20.46 Bn
2 Johnson & Johnson 685.50 Bn 605.36 Bn 17.30 Bn
3 AbbVie 526.37 Bn 494.37 Bn 13.12 Bn
4 Merck 362.03 Bn 324.97 Bn 13.19 Bn
5 Novartis Ag 313.25 Bn 286.48 Bn -
6 Astrazeneca 286.56 Bn 260.08 Bn 13.26 Bn
7 Amgen 253.40 Bn 205.05 Bn 7.58 Bn
8 Gilead Sciences 210.31 Bn 185.42 Bn 6.73 Bn
9 Pfizer 165.24 Bn 112.60 Bn 12.56 Bn
10 Kyntra Bio 13.32 Mn -394.63 Mn 1.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 52.97
Jun 30, 2019 59.35
API Access

Kyntra Bio EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=KYNB&period=max&api_key=YOUR_API_KEY